Revision as of 14:51, 17 May 2024

Back to Top

The "How I Treat" series has been published by Blood for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles are not considered to be formal guidelines, they are considered highly reputable sources of expert opinion. They cover topics ranging from commonly encountered hematologic conditions with a large evidence base, to very rare conditions with only case reports to guide treatment. The purpose of this page is to consolidate the links to all known published How I Treat articles.

In the first two sections (malignant hematology and classical hematology), articles are presented by condition, in reverse chronological order. In the third section, articles are gathered under "special considerations" such as pregnancy and hematologic disease. The fourth section contains miscellaneous topics that do not easily fit into the above categories. Given the rapid change in evidence in many areas of hematology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Malignant hematology

Acute leukemias

Mixed-phenotype acute leukemia (MPAL)

2015: Wolach & Stone. How I treat mixed-phenotype acute leukemia PubMed

Myeloid neoplasms

Lymphoid neoplasms

Adult T-cell leukemia-lymphoma (ATLL)

2021: Cook & Phillips How I treat adult T-cell leukemia/lymphoma PubMed

Anaplastic large cell lymphoma

2018: Metha-Shah et al. How I treat breast implant-associated anaplastic large cell lymphoma PubMed

Burkitt lymphoma (BL)

2018: Gopal & Gross. How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa PubMed
2014: Jacobson & LaCasce. How I treat Burkitt lymphoma in adults PubMed

Castleman disease

2010: Bower. How I treat HIV-associated multicentric Castleman disease PubMed

Chronic lymphocytic leukemia (CLL/SLL)

2021: Lew et al. How I treat chronic lymphocytic leukemia after venetoclax
2019: Stephens & Byrd. How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia
2018: Brown. How I treat CLL patients with ibrutinib PubMed
2018: Gribben. How and when I do allogeneic transplant in CLL PubMed
2017: Woyach. How I manage ibrutinib-refractory chronic lymphocytic leukemia PubMed
2009: Gribben. How I treat CLL up front PubMed

Classical Hodgkin lymphoma (cHL)

2021: Epperla & Herrera. How I incorporate novel agents into the treatment of classical Hodgkin lymphoma
2015: Alinari & Blum. How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant PubMed
2014: Uldrick & Little. How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus PubMed

CNS lymphoma

2023: Alderuccio et al. How I treat secondary CNS involvement by aggressive lymphomas PubMed
2017: Chin & Cheah. How I treat patients with aggressive lymphoma at high risk of CNS relapse PubMed
2013: Rubenstein et al. How I treat CNS lymphomas PubMed

Cutaneous T-cell lymphoma (CTCL)

2019: Shinohara & Shustov. How I treat primary cutaneous CD30 + lymphoproliferative disorders
2016: Whittaker et al. How I treat mycosis fungoides and Sézary syndrome PubMed

Diffuse large B-cell lymphoma (DLBCL)

2023: Lugtenburg & Mutsaers. How I treat older patients with DLBCL in the frontline setting PubMed

Follicular lymphoma (FL)

2019: Casulo & Barr. How I treat early-relapsing follicular lymphoma PubMed

High-grade B-cell lymphoma (HGBL)

2017: Friedberg. How I treat double-hit lymphoma PubMed

HIV-associated lymphoma

2014: Uldrick & Little. How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus PubMed
2012: Dunleavy & Wilson. How I treat HIV-associated lymphoma PubMed
2010: Bower. How I treat HIV-associated multicentric Castleman disease PubMed

Large granular lymphocytic leukemia (T-LGL)

2011: Lamy & Loughran. How I treat LGL leukemia PubMed

Mantle cell lymphoma (MCL)

2009: Ghielmini & Zucca. How I treat mantle cell lymphoma PubMed

NK- and T-cell lymphoma (NKTCL)

2013: Tse & Kwong. How I treat NK/T-cell lymphomas PubMed

Nodular lymphocyte-predominant Hodgkin lymphoma (NLP-HL)

2020: Eichenauer & Engert. How I treat nodular lymphocyte-predominant Hodgkin Lymphoma
2013: Advani & Hoppe. How I treat nodular lymphocyte predominant Hodgkin lymphoma PubMed

Peripheral T-cell lymphoma (PTCL)

2014: Moskowitz et al. How I treat the peripheral T-cell lymphomas PubMed

Post-transplant lymphoproliferative disorder (PTLD)

2023: Amengual & Pro. How I treat posttransplant lymphoproliferative disorder PubMed
2015: Dierickx et al. How I treat posttransplant lymphoproliferative disorders PubMed

Primary mediastinal B-cell lymphoma (PMBCL)

2018: Giulino-Roth. How I treat primary mediastinal B-cell lymphoma PubMed

Prolymphocytic leukemia (T-PLL)

2012: Dearden. How I treat prolymphocytic leukemia PubMed

Splenic lymphoma

2011: Iannitto & Tripodo. How I diagnose and treat splenic lymphomas PubMed

Transformed lymphoma

2014: Parikh et al. How we treat Richter syndrome PubMed

Waldenström macroglobulinemia (WM)

2024: Treon et al. How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia PubMed
2019: Dimopoulos & Kastritis. How I treat Waldenström macroglobulinemia PubMed
2015: Treon. How I treat Waldenström macroglobulinemia PubMed

Plasma cell dyscrasias

Light-chain (AL) amyloidosis

2022: Palladini & Merlini. How I treat AL amyloidosis
2012: Leung et al. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing PubMed

MGUS

2013: Fermand et al. How I treat monoclonal gammopathy of renal significance (MGRS) PubMed

Multiple myeloma (MM)

2023: van de Donk. How We Manage Newly Diagnosed Multiple Myeloma With Circulating Tumor Cells
2022: Kastritis et al. How I treat relapsed multiple myeloma
2022: Perrot. How I treat frontline transplantation-eligible multiple myeloma PubMed
2022: Vaxman & Gertz. How I approach smoldering multiple myeloma
2022: Zamagni et al. How I treat high-risk multiple myeloma
2017: Harousseau & Attal. How I treat first relapse of myeloma PubMed
2017: Moreau. How I treat myeloma with new agents PubMed
2015: Larocca & Palumbo. How I treat fragile myeloma patients PubMed
2015: Lonial et al. How I treat high-risk myeloma PubMed
2015: Touzeau & Moreau. How I treat extramedullary myeloma PubMed
2014: Bladé et al. How I treat relapsed myeloma PubMed
2014: Gertz & Dingli. How we manage autologous stem cell transplantation for patients with multiple myeloma PubMed
2010: Mehta et al. How I treat elderly patients with myeloma PubMed
2009: Stewart et al. How I treat multiple myeloma in younger patients PubMed

Plasma cell leukemia (PCL)

2012: van de Donk et al. How I treat plasma cell leukemia PubMed

Smoldering multiple myeloma (SMM)

2014: Ghobrial & Landgren. How I treat smoldering multiple myeloma PubMed

Histiocytic disorders

Hemophagocytic lymphohistiocytosis (HLH)

2015: Schram & Berliner. How I treat hemophagocytic lymphohistiocytosis in the adult patient PubMed

Langerhans cell histiocytosis (LCH)

2015: Allen et al. How I treat Langerhans cell histiocytosis PubMed

Classical hematology

Hemostasis and thrombosis

2023: Samuelson Bannow & Konkle. How I approach bleeding in hospitalized patients PubMed
2021: Baker & O'Donnell. How I treat bleeding disorder of unknown cause PubMed
2016: Martin & Key. How I treat patients with inherited bleeding disorders who need anticoagulant therapy PubMed
2015: Pavord & Maybury. How I treat postpartum hemorrhage PubMed
2014: Johansson et al. How I treat patients with massive hemorrhage PubMed
2014: Levy & Goodnough. How I use fibrinogen replacement therapy in acquired bleeding PubMed

Acquired thrombotic thrombocytopenic purpura (aTTP)

2022: Akwaa et al. How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge
2020: Ferrari & Peyvandi. How I treat thrombotic thrombocytopenic purpura in pregnancy
2015: Sayani & Abrams. How I treat refractory thrombotic thrombocytopenic purpura PubMed

Antiphospholipid antibody syndrome (APS)

2024: Branch & Lim How I diagnose and treat antiphospholipid syndrome in pregnancy PubMed
2021: Cohen & Isenberg. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome PubMed
2015: Ortel et al. How I treat catastrophic thrombotic syndromes PubMed

Arterial thromboembolism (ATE)

2020: May & Moll. How I treat unexplained arterial thrombosis

Disseminated intravascular coagulation (DIC)

2018: Levi & Scully. How I treat disseminated intravascular coagulation PubMed

Hemophilia

2020: Leebeek et al. How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease
2019: Young. How I treat children with haemophilia and inhibitors
2015: Leissinger et al. How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors PubMed
2012: Mannucci & Mancuso. How we choose factor VIII to treat hemophilia PubMed

Heparin-induced thrombocytopenia (HIT)

2016: Warkentin & Anderson. How I treat patients with a history of heparin-induced thrombocytopenia PubMed

Thrombotic microangiopathy (TMA)

2023: Doreille et al. How I treat thrombotic microangiopathy in the era of rapid genomics
2021: Thomas & Scully. How I treat microangiopathic hemolytic anemia in patients with cancer

Venous thromboembolism (VTE)

2023: Akpan & Hunt. How I approach the prevention and treatment of thrombotic complications in hospitalized patients PubMed
2022: Schmidt & Lee. How I treat and prevent venous thrombotic complications in patients with lymphoma
2020: Klok & Huisman. How I assess and manage the risk of bleeding in patients treated for venous thromboembolism
2020: Middeldorp & Ganzevoort. How I treat venous thromboembolism in pregnancy
2020: Wang & Carrier. How I treat obese patients with oral anticoagulants
2019: Pabinger & Thaler. How I treat patients with hereditary antithrombin deficiency
2019: Chan & Eikelbloom. How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism
2019: Kraaijpoel & Carrier. How I treat cancer-associated venous thromboembolism
2018: Rabinovich & Kahn. How I treat the postthrombotic syndrome PubMed
2018: Shet & Wun. How I diagnose and treat venous thromboembolism in sickle cell disease
2018: Vedantham & Sista. How I use catheter-directed interventional therapy to treat patients with venous thromboembolism PubMed
2017: Schulman. How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy PubMed
2017: Young. How I treat pediatric venous thromboembolism PubMed
2015: Kyrle. How I treat recurrent deep-vein thrombosis PubMed
2015: O'Connell. How I treat incidental pulmonary embolism PubMed
2014: Ageno et al. How I treat splanchnic vein thrombosis PubMed
2014: Palareti. How I treat isolated distal deep vein thrombosis (IDDVT) PubMed
2012: Dobromirski & Cohen. How I manage venous thromboembolism risk in hospitalized medical patients PubMed

von Willebrand disease (vWD)

2020: Biguzzi et al. How I treat gastrointestinal bleeding in congenital and acquired von Willebrand disease
2020: Leebeek et al. How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease
2019: Lavin & O'Donnell. How I treat low von Willebrand factor levels
2018: Kruse-Jarres & Johnsen. How I treat type 2B von Willebrand disease PubMed
2014: Tosetto & Castaman. How I treat type 2 variant forms of von Willebrand disease PubMed
2011: Tiede et al. How I treat the acquired von Willebrand syndrome PubMed

Cytopenias

Acquired pure red cell aplasia

2021: Gurnari & Maciejewski. How I manage acquired pure red cell aplasia in adults PubMed

Anemia

2023: Carson & Brittenham. How I treat anemia with red blood cell transfusion and iron PubMed
2021: Gurnari & Maciejewski. How I manage acquired pure red cell aplasia in adults
2020: Anand & Gupta. How I treat anemia in heart failure
2020: Fishbane & Coyne. How I treat renal anemia
2020: Gilreath & Rodgers. How I treat cancer-associated anemia
2020: Shander et al. How I treat anemia in the perisurgical setting
2016: Achebe & Gafter-Gvili. How I treat anemia in pregnancy: iron, cobalamin, and folate PubMed
2014: Hershko & Camaschella. How I treat unexplained refractory iron deficiency anemia

Aplastic anemia

2017: Bacigalupo. How I treat acquired aplastic anemia PubMed

Autoimmune cytopenia

2022: Porpaczy & Jäger. How I manage autoimmune cytopenias in patients with lymphoid cancer PubMed

Immune thrombocytopenia (ITP)

2021: Ghanima et al. How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment
2016: Cuker & Neunert. How I treat refractory immune thrombocytopenia PubMed

Neutropenia & leukopenia

2014: Gibson & Berliner. How we evaluate and treat neutropenia in adults PubMed

Thrombocytopenia and platelet dysfunction

2024: Fogerty & Kuter How I treat thrombocytopenia in pregnancy PubMed
- 2012: Gernsheimer et al. How I treat thrombocytopenia in pregnancy PubMed
2023: Stanworth & Mumford. How I diagnose and treat neonatal thrombocytopenia PubMed
2022: Stanworth & Shah. How I use platelet transfusions PubMed
2022: Fiore et al. How I manage pregnancy in women with Glanzmann thrombasthenia
2021: Kyrle & Eichinger. How I manage cyclic thrombocytopenia
2016: Greinacher & Selleng. How I evaluate and treat thrombocytopenia in the intensive care unit patient PubMed

WHIM syndrome

2017: Badolato et al. How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome PubMed

Hemoglobinopathies

Beta thalassemia

2023: Saliba et al. How I treat non-transfusion-dependent β-thalassemia PubMed
2018: Taher & Cappellini. How I manage medical complications of β-thalassemia in adults PubMed

Sickle cell disease

2024: James & Strouse How I treat sickle cell disease in pregnancy PubMed
2019: Stenger et al. How I treat sickle cell disease with hematopoietic cell transplantation
2018: Pirenne & Yazdanbakhsh. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions PubMed
2018: Shet & Wun. How I diagnose and treat venous thromboembolism in sickle cell disease
2018: Thein & Howard. How I treat the older adult with sickle cell disease
2015: Anele et al. How I treat priapism PubMed
2015: Kassim et al. How I treat and manage strokes in sickle cell disease PubMed
2014: Sharpe & Thein. How I treat renal complications in sickle cell disease PubMed

Hemolytic disorders

2018: Machogu & Machado. How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders PubMed
2017: Go et al. How I treat autoimmune hemolytic anemia PubMed

Cold agglutinin disease (CAD)

2021: Berentsen. How I treat cold agglutinin disease

Atypical hemolytic uremic syndrome (aHUS)

2023: Fakhouri et al. How I diagnose and treat atypical hemolytic uremic syndrome PubMed
2014: Cataland & Wu. How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome PubMed

Paroxysmal nocturnal hemoglobinuria (PNH)

2021: Brodsky. How I treat paroxysmal nocturnal hemoglobinuria
2009: Brodsky. How I treat paroxysmal nocturnal hemoglobinuria PubMed

Warm autoimmune hemolytic anemia (WAIHA)

2021: Barcellini & Fattizzo. How I treat warm autoimmune hemolytic anemia

Special considerations

Age-based recommendations

The majority of How I Treat articles focus on "standard" adults; below, articles that focus on other age populations are concatenated.

Neonates

2023: Stanworth & Mumford How I diagnose and treat neonatal thrombocytopenia PubMed
2018: Brown et al. How I treat infant leukemia PubMed

Children

2023: Myers et al. How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL PubMed
2023: Si Lim et al. How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults PubMed
2021: Rubnitz & Kaspers. How I treat pediatric acute myeloid leukemia PubMed
2020: Hunger & Raetz. How I treat relapsed acute lymphoblastic leukemia in the pediatric population PubMed
2020: Teachey & O'Connor How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children PubMed
2019: Hijiya & Suttorp. How I treat chronic myeloid leukemia in children and adolescents
2018: Gopal & Gross. How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa PubMed
2018: Locatelli & Strahm. How I treat myelodysplastic syndromes of childhood PubMed
2017: Young. How I treat pediatric venous thromboembolism PubMed
2012: Locatelli et al. How I treat relapsed childhood acute lymphoblastic leukemia PubMed

Adolescents and young adults (AYA)

2023: Si Lim et al. How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults PubMed
2019: Hijiya & Suttorp. How I treat chronic myeloid leukemia in children and adolescents
2019: Young. How I treat children with haemophilia and inhibitors
2018: Gopal & Gross. How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa PubMed
2015: Curran & Stock. How I treat acute lymphoblastic leukemia in older adolescents and young adults PubMed

Older adults

2023: Lugtenburg & Mutsaers How I treat older patients with DLBCL in the frontline setting PubMed
2019: Chan & Eikelbloom. How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism
2018: Thein & Howard. How I treat the older adult with sickle cell disease
2014: Ossenkoppele & Löwenberg. How I treat the older patient with acute myeloid leukemia PubMed
2013: Gökbuget. How I treat older patients with ALL PubMed
2010: Mehta et al. How I treat elderly patients with myeloma PubMed

Complications of treatment

Bleeding

2017: Boonyawat et al. How I treat heavy menstrual bleeding associated with anticoagulants PubMed
2014: Schulman & Furie. How I treat poisoning with vitamin K antagonists PubMed
2014: Siegal et al. How I treat target-specific oral anticoagulant-associated bleeding PubMed

Cardiovascular complications

2022: Herrmann et al. How I treat cardiovascular complications in patients with lymphoid malignancies PubMed

Immune effector cells toxicity management

2023: Gutierrez et al. How I approach optimization of patients at risk of cardiac and pulmonary complications after CAR T-cell therapy PubMed
2023: Jain et al. How I treat refractory CRS and ICANS after CAR T-cell therapy PubMed
2023: Jain et al. How I treat cytopenias after CAR T-cell therapy PubMed
2023: Santomasso et al. How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicity PubMed
2020: Hill & Seo How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies

Infectious complications

2023: Dadwal et al. How I prevent viral reactivation in high-risk patients PubMed
2022: El Chaer et al. How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies PubMed
2022: Law & Taplitz. How I manage infection risk and prevention in patients with lymphoid cancer PubMed
2020: Hill & Seo. How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
2016: El Chaer et al. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients PubMed
2016: Waghmare et al. How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation PubMed
2014: Nucci & Anaissie. How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach PubMed

Iron overload

2012: Hoffbrand et al. How I treat transfusional iron overload PubMed

Medication toxicities

2017: Delforge & Ludwig. How I manage the toxicities of myeloma drugs PubMed

Neurologic medications

2022: Nayak & Batchelor. How I treat neurologic complications in patients with lymphoid cancer PubMed

Genetic risk

2023: Hamilton et al. How I communicate with patients and families about germ line genetic information PubMed
2016: University of Chicago Hematopoietic Malignancies Cancer Risk Team How I diagnose and manage individuals at risk for inherited myeloid malignancies PubMed

Gynecologic considerations

Menstruation

2017: Boonyawat et al. How I treat heavy menstrual bleeding associated with anticoagulants PubMed

Pregnancy

2024: Branch & Lim How I diagnose and treat antiphospholipid syndrome in pregnancy PubMed
2024: Fogerty & Kuter How I treat thrombocytopenia in pregnancy PubMed
- 2012: Gernsheimer et al. How I treat thrombocytopenia in pregnancy PubMed
2024: James & Strouse How I treat sickle cell disease in pregnancy PubMed
2024: Robinson et al. How I treat myeloproliferative neoplasms in pregnancy PubMed
2022: Fiore et al. How I manage pregnancy in women with Glanzmann thrombasthenia
2020: Dunleavy & McLintock. How I treat lymphoma in pregnancy
2020: Ferrari & Peyvandi. How I treat thrombotic thrombocytopenic purpura in pregnancy
2020: Leebeek et al. How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease
2020: Middeldorp & Ganzevoort. How I treat venous thromboembolism in pregnancy
2016: Achebe & Gafter-Gvili. How I treat anemia in pregnancy: iron, cobalamin, and folate PubMed
2013: Milojkovic & Apperley. How I treat leukemia during pregnancy PubMed

Postpartum period

2015: Pavord & Maybury. How I treat postpartum hemorrhage PubMed

Hospitalization

2023: Akpan & Hunt. How I approach the prevention and treatment of thrombotic complications in hospitalized patients PubMed
2023: Samuelson Bannow & Konkle. How I approach bleeding in hospitalized patients PubMed
2023: Zon & Berliner. How I manage inpatient consultations for quantitative neutrophil abnormalities in adults PubMed
2012: Dobromirski & Cohen. How I manage venous thromboembolism risk in hospitalized medical patients PubMed

Regional considerations

2018: Gopal & Gross. How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa PubMed

Surgical considerations

2020: Shander et al. How I treat anemia in the perisurgical setting
2012: Spyropoulos & Douketis. How I treat anticoagulated patients undergoing an elective procedure or surgery PubMed

Transplantation

Allogeneic HSCT

2024: Mina et al. How I reduce and treat posttransplant relapse of MDS PubMed
2023: DeFilipp & Chen. How I treat with maintenance therapy after allogeneic HCT PubMed
2021: Burns & Morris. How I use allogeneic HSCT for adults with inborn errors of immunity PubMed
2020: Puerta-Alcalde et al. How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease PubMed
2019: McCurdy & Luznik. How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide PubMed
2018: Gribben. How and when I do allogeneic transplant in CLL PubMed
2017: Alvarnas et al. How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation PubMed
2017: Williams. How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation PubMed
2016: El Chaer et al. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients PubMed
2012: Wingard et al. How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation PubMed

Autologous HSCT

2014: Gertz & Dingli. How we manage autologous stem cell transplantation for patients with multiple myeloma PubMed

Graft versus host disease (GVHD)

2023: Cooper & Abkowitz. How I diagnose and treat acute graft-versus-host disease after solid organ transplantation
2023: Rimando et al. How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond
2020: Martin. How I treat steroid-refractory acute graft-versus-host disease PubMed
2019: Sarantopoulos et al. How I treat refractory chronic graft-versus-host disease
2016: McDonald. How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver PubMed
2014: Flowers & Martin. How we treat chronic graft-versus-host disease
2012: Treister et al. How we treat oral chronic graft-versus-host disease PubMed
2007: Deeg. How I treat refractory acute GVHD PubMed

Miscellaneous

Atrial fibrillation

2016: Steinberg. How I use anticoagulation in atrial fibrillation PubMed

Cryoglobulinemia

2016: Muchtar et al. How I treat cryoglobulinemia PubMed

Immunodeficiency

Common variable immune deficiency (CVID)

2010: Cunningham-Rundles. How I treat common variable immune deficiency PubMed

Severe combined immunodeficiency (SCID)

2013: Gaspar et al. How I treat severe combined immunodeficiency PubMed

Priapism

2015: Anele et al. How I treat priapism PubMed

Protoporphyria

2023: Karp Leaf & Dickey. How I treat erythropoietic protoporphyria and X-linked protoporphyria PubMed

T-cell chronic active Epstein-Barr virus disease (CAEBV)

2018: Bollard & Cohen. How I treat T-cell chronic active Epstein-Barr virus disease PubMed

@@ Line 56: / Line 56: @@
 ===[[Chronic myelomonocytic leukemia|Chronic myelomonocytic leukemia (CMML)]]===
 *'''2017:''' Solary & Itzykson. [https://doi.org/10.1182/blood-2017-04-736421 How I treat chronic myelomonocytic leukemia] [https://pubmed.ncbi.nlm.nih.gov/28572287/ PubMed]
-===[[Essential thrombocythemia|Essential thrombocythemia (ET)]]===
-*'''2018:''' Odenike. [https://doi.org/10.1182/blood-2018-03-785907 How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms] [https://pubmed.ncbi.nlm.nih.gov/30333119/ PubMed]
-*'''2016:''' Rumi & Cazzola. [https://doi.org/10.1182/blood-2016-05-643346 How I treat essential thrombocythemia] [https://pubmed.ncbi.nlm.nih.gov/27561316/ PubMed]
 ===[[Hypereosinophilic syndrome|Hypereosinophilic syndrome (HES)]]===
@@ Line 72: / Line 68: @@
 *'''2013:''' Fenaux & Adès. [https://doi.org/10.1182/blood-2013-02-453068 How we treat lower-risk myelodysplastic syndromes]
-===[[Myelofibrosis|Myelofibrosis (MF)]]===
+===[[:Category:Myeloproliferative_neoplasms|Myeloproliferative neoplasms (MPNs)]]===
+*'''2024:''' Robinson et al. [https://doi.org/10.1182/blood.2023020729 How I treat myeloproliferative neoplasms in pregnancy] [https://pubmed.ncbi.nlm.nih.gov/38145575/ PubMed]
+*'''2018:''' Odenike. [https://doi.org/10.1182/blood-2018-03-785907 How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms] [https://pubmed.ncbi.nlm.nih.gov/30333119/ PubMed]
+====[[Essential thrombocythemia|Essential thrombocythemia (ET)]]====
+*'''2016:''' Rumi & Cazzola. [https://doi.org/10.1182/blood-2016-05-643346 How I treat essential thrombocythemia] [https://pubmed.ncbi.nlm.nih.gov/27561316/ PubMed]
+====[[Myelofibrosis|Myelofibrosis (MF)]]====
 *'''2023:''' Kröger et al. [https://doi.org/10.1182/blood.2023021218 How I treat transplant-eligible patients with myelofibrosis] [https://pubmed.ncbi.nlm.nih.gov/37647853/ PubMed]
-*'''2018:''' Odenike. [https://doi.org/10.1182/blood-2018-03-785907 How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms] [https://pubmed.ncbi.nlm.nih.gov/30333119/ PubMed]
 *'''2018:''' Pardanani & Tefferi. [https://doi.org/10.1182/blood-2018-02-785923 How I treat myelofibrosis after failure of JAK inhibitors] [https://pubmed.ncbi.nlm.nih.gov/29866811/ PubMed]
 *'''2011:''' Tefferi. [https://doi.org/10.1182/blood-2010-11-315614 How I treat myelofibrosis] [https://pubmed.ncbi.nlm.nih.gov/21200024/ PubMed]
-===[[Polycythemia vera|Polycythemia vera (PV)]]===
+====[[Polycythemia vera|Polycythemia vera (PV)]]====
 *'''2019:''' Spivak. [https://doi.org/10.1182/blood.2018834044 How I treat polycythemia vera] [https://pubmed.ncbi.nlm.nih.gov/31151982/ PubMed]
-*'''2018:''' Odenike. [https://doi.org/10.1182/blood-2018-03-785907 How I treat the blast phase of Philadelphia chromosome-negative myeloproliferative neoplasms] [https://pubmed.ncbi.nlm.nih.gov/30333119/ PubMed]
 *'''2014:''' Vannucchi. [https://doi.org/10.1182/blood-2014-07-551929 How I treat polycythemia vera] [https://pubmed.ncbi.nlm.nih.gov/25278584/ PubMed]

Difference between revisions of "How I Treat"